SUPINDER CHANNA: Open Payments
NPI 1427509611 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,629 in 126 payments from 19 companies in 2025. Trend: 2023 $1,954 · 2024 $1,655 · 2025 $2,629
Food & beverage: $2,629
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $657 |
| Electromed, Inc. | 22 | $269 |
| GlaxoSmithKline, LLC. | 19 | $257 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $167 |
| GENZYME CORPORATION | 8 | $157 |
| Regeneron Healthcare Solutions, Inc. | 8 | $142 |
| Verona Pharma, Inc. | 10 | $142 |
| United Therapeutics Corporation | 7 | $140 |
| Merck Sharp & Dohme LLC | 4 | $108 |
| Viatris Specialty LLC | 6 | $105 |
Products named: FASENRA, DUPIXENT, AIRSUPRA, SMARTVEST, NUCALA, Ohtuvayre, Tyvaso, WINREVAIR.
Industry payments across SC — which companies pay providers there.
